VOI - Voice of Indonesia | RRI - Radio Republik Indonesia

Minister of Finance Sri Mulyani Indrawati provided fiscal facilities in the form of tax exemption worth IDR 50.95 billion for the 1.2 million Sinovac vaccines that arrived in Indonesia on Sunday (6/12) with an estimated import value of US $20.5 million.

"Exemption from import duty and/or excise is not subject to Value Added Tax (PPN) and Luxury Goods Sales Added Tax (PPnBM) and exemption from Article 22 Income Tax (PPh)," Sri Mulyani said in a virtual press statement in Jakarta, Monday.

Minister of Finance Sri Mulyani specified that the exemption from import duty was Rp. 14.56 billion and import tax of Rp. 36.39 billion for 1.2 million vials for one dose of vaccine, and 568 vials for one dose of vaccine for the test sample.

The minister explained that 1.2 million COVID-19 vaccines were imported from Sinovac Lifescience Corporation Limited China as SARS CoV-2 or verocells with BUMN recipients, Bio Farma.

The vaccine, continued by the former World Bank Managing Director, was packaged in 33 packages with a gross weight of 9,229 kilograms according to AWB Number PEK-99463221.

According to him, the fiscal facility was provided to help import the COVID-19 vaccine based on Presidential Regulation Number 99 of 2020 and the derivative regulations of the Minister of Finance Regulation (PMK) 188 / PMK.04 / 2020.

The PMK regulates the provision of customs and/or excise facilities as well as import taxation of vaccines for handling the COVID-19 pandemic.

Subjects in the PMK, he said, are the central government, namely the Ministry of Health, the Food and Drug Supervisory Agency (BPOM), local governments, and legal or non-legal entities that have been assigned or appointed by the Ministry of Health.

Meanwhile, the objects given this fiscal facility include vaccines, vaccine raw materials, equipment for vaccine production because vaccines will also be sent in the form of bulk materials and equipment for vaccination.

In addition to the 1.2 million vaccines, the government is also working on 1.8 million doses that will arrive in early January 2021.

Apart from being in finished form, the plan is that in December 2020 there will also be 15 million doses of vaccine and in January 2021 the plan is as many as 30 million doses in form of bulk raw materials which will be further processed by Bio Farma. (Antaranews)